FDA.reportPublic FDA data

maralixibat 19 MG/ML Oral Solution [Livmarli]

RxCUI
2690992
RxNorm name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Display name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Full name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivmarliMARALIXIBAT CHLORIDEMirum Pharmaceuticals Inc.64000394-1ef6-4e76-8ba8-11f25ba1b1672025-04-10Warnings, Adverse reactionsExact identifier
rxcui: 2690992

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
64000394-1ef6-4e76-8ba8-11f25ba1b167Livmarli 19 MG/mL Oral Solution [PSN] · maralixibat 19 MG/ML Oral Solution [Livmarli] [SBD] · Livmarli 19 MG/ML Oral Solution [SY]311These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 202120250410